Literature DB >> 11805657

Nerve fibers in lumbar spine structures and injured spinal roots express the sensory neuron-specific sodium channels SNS/PN3 and NaN/SNS2.

Andrew T Bucknill1, Kevin Coward, Christopher Plumpton, Simon Tate, Chas Bountra, Rolfe Birch, Ann Sandison, Sean P F Hughes, Praveen Anand.   

Abstract

STUDY
DESIGN: This prospective study examined the innervation of lumbar spine in tissues from patients with lower back pain and spine nerve roots from patients with traumatic brachial plexus injuries.
OBJECTIVES: To demonstrate the presence of nerve fibers in lumbar spine structures and spine nerve roots, and to determine whether they express the sensory neuron-specific sodium channels SNS/PN3 and NaN/SNS2. SUMMARY OF BACKGROUND DATA: The anatomic and molecular basis of low back pain and sciatica is poorly understood. Previous studies have demonstrated sensory nerves in the facet joint capsule and prolapsed intervertebral disc, but not in the ligamentum flavum. The voltage-gated sodium channels SNS/PN3 and NaN/SNS2 are expressed by sensory neurone that mediate pain, but their presence in the lumbar spine is unknown.
METHODS: Tissue samples of ligamentum flavum (n = 32), facet joint capsule (n = 20), intervertebral disc (n = 15), and spine roots (n = 8) were immunostained with specific antibodies to protein gene product 9.5 (a panneuronal marker), SNS/PN3, and NaN/SNS2.
RESULTS: Protein gene product 9.5 immunoreactive nerve fibers were detected in 72% of the ligamentum flavum specimens and 70% of the facet joint capsule specimens, but in only 20% of the intervertebral disc specimens. The study detected SNS/PN3- and NaN/SNS2-positive fibers, respectively, in 28% and 3% of the ligamentum flavum specimens and 25% and 15% of the facet joint capsule specimens. Numerous SNS/PN3- and NaN/SNS2-positive fibers were found in the acutely injured spine roots, and some were still present in the dorsal roots in the chronic state.
CONCLUSIONS: As the findings showed, SNS/PN3- and NaN/SNS2-immunoreactivity is present in a subset of nerve fibers in lumbar spine structures, including ligamentum flavum, and in injured spine roots. Selective SNS/PN3- and NaN/SNS2-blocking agents may provide new therapy for back pain and sciatica.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805657     DOI: 10.1097/00007632-200201150-00003

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

1.  An evaluation of contrast dispersal pattern on preganglionic epidural injection through trans-lateral recess approach in patients with lumbosacral radiculopathy.

Authors:  Min Seok Kang; Jin Ho Hwang; Joon Sik Ahn
Journal:  Eur Spine J       Date:  2019-03-25       Impact factor: 3.134

2.  The impact of sagittal balance on low back pain in patients treated with zygoapophysial facet joint injection.

Authors:  L Proietti; G R Schirò; S Sessa; L Scaramuzzo
Journal:  Eur Spine J       Date:  2014-09-12       Impact factor: 3.134

3.  Detailed pathological changes of human lumbar facet joints L1-L5 in elderly individuals.

Authors:  Thomas Tischer; Thomas Aktas; Stefan Milz; Reinhard V Putz
Journal:  Eur Spine J       Date:  2005-07-15       Impact factor: 3.134

Review 4.  Challenges in the development of novel treatment strategies for neuropathic pain.

Authors:  Michael H Ossipov; Frank Porreca
Journal:  NeuroRx       Date:  2005-10

Review 5.  Innervation of the Human Intervertebral Disc: A Scoping Review.

Authors:  Adam M R Groh; Dale E Fournier; Michele C Battié; Cheryle A Séguin
Journal:  Pain Med       Date:  2021-06-04       Impact factor: 3.750

6.  Functional up-regulation of Nav1.8 sodium channel in Aβ afferent fibers subjected to chronic peripheral inflammation.

Authors:  Mounir Belkouch; Marc-André Dansereau; Pascal Tétreault; Michael Biet; Nicolas Beaudet; Robert Dumaine; Ahmed Chraibi; Stéphane Mélik-Parsadaniantz; Philippe Sarret
Journal:  J Neuroinflammation       Date:  2014-03-07       Impact factor: 8.322

7.  muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits.

Authors:  J Ekberg; A Jayamanne; C W Vaughan; S Aslan; L Thomas; J Mould; R Drinkwater; M D Baker; B Abrahamsen; J N Wood; D J Adams; M J Christie; R J Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.